Methyl Anthranilate

Methyl Anthranilate

SCHEMBL901249

COC(=O)c1ccccc1N.COC(=O)c1ccccc1N

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 1.00
HSD17B10 Q99714 10/20 1.00
CFTR P13569 2/20 1.00
TSHR P16473 6/20 0.61
LMNA P02545 1/20 0.61
KDM4E B2RXH2 8/20 0.58
GLA P06280 4/20 0.58
HPGD P15428 4/20 0.58
GAA P10253 3/20 0.58
MAPT P10636 3/20 0.58
ATM Q13315 2/20 0.58
CASP1 P29466 1/20 0.58
CASP7 P55210 1/20 0.58
POLB P06746 3/20 0.57
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA5A P35218 1/20 0.56
CA9 Q16790 1/20 0.56
ABL1 P00519 1/20 0.56
ALOX15 P16050 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Anthranilate SCHEMBL29564148 1.00 ALDH1A1 (1.00) ALDH1A1HSD17B10CFTRTSHRLMNA
Methyl Anthranilate SCHEMBL29444250 1.00 ALDH1A1 (1.00) ALDH1A1HSD17B10CFTRTSHRLMNA
Methyl Anthranilate SCHEMBL57713 1.00 ALDH1A1 (1.00) ALDH1A1HSD17B10CFTRTSHRLMNA
Methyl Anthranilate SCHEMBL27738549 0.98 ALDH1A1 (0.96) ALDH1A1HSD17B10CFTRTSHRLMNA
Methyl Anthranilate SCHEMBL27983298 0.98 ALDH1A1 (0.96) ALDH1A1HSD17B10CFTRTSHRLMNA
Methyl Anthranilate SCHEMBL5317613 0.98 ALDH1A1 (0.96) ALDH1A1HSD17B10CFTRTSHRLMNA
Methyl Anthranilate SCHEMBL17783869 0.98 ALDH1A1 (0.96) ALDH1A1HSD17B10CFTRTSHRLMNA
Methyl Anthranilate SCHEMBL28144115 0.98 ALDH1A1 (0.96) ALDH1A1HSD17B10CFTRTSHRLMNA
Methyl Anthranilate SCHEMBL7462337 0.98 ALDH1A1 (0.96) ALDH1A1HSD17B10CFTRTSHRLMNA
Methyl Anthranilate SCHEMBL28010183 0.98 ALDH1A1 (0.96) ALDH1A1HSD17B10CFTRTSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114432175-A Pet skin care agent 佛山市佛丹动物药业有限公司 2022-05-06 CN disclosed
US-11062794-B2 Olfactory signature and odorant mixture having the same YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2021-07-13 US disclosed
CN-108967424-A Imagoes of Harmonia Axyridis botanical attractant and its screening, test and application method 扬州大学 2018-12-11 CN disclosed
US-20180253534-A1 OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2018-09-06 US disclosed
EP-3307231-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF The Procter and Gamble Company (US) 2018-04-18 EP disclosed
EP-3307393-A1 FRAGRANCE COMPOSITION The Procter and Gamble Company (US) 2018-04-18 EP disclosed
EP-3307394-A1 FRAGRANCE FIXATIVES AND COMPOSITIONS COMPRISING THEREOF The Procter and Gamble Company (US) 2018-04-18 EP disclosed
EP-3274434-A1 PERFUME COMPOSITIONS Johnson & Johnson Consumer Inc. (US) 2018-01-31 EP disclosed
WO-2017131818-A1 PERFUME COMPOSITIONS JOHNSON & JOHNSON CONSUMER INC. (US) 2017-08-03 WO disclosed
CN-106509412-A Cattle feed containing Chinese herbs, and preparation method thereof 宾阳县阳光农村产业农民专业合作社 2017-03-22 CN disclosed
WO-2015089246-A1 FRAGRANCE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2015-06-18 WO disclosed
EP-2621462-A1 ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR The Procter and Gamble Company (US) 2013-08-07 EP disclosed
WO-2013035070-A1 OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2013-03-14 WO disclosed
EP-2496682-A1 DELIVERY PARTICLE The Procter & Gamble Company (US) 2012-09-12 EP disclosed
WO-2012044728-A1 ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR THE PROCTER & GAMBLE COMPANY (US) 2012-04-05 WO disclosed
WO-2011056935-A1 DELIVERY PARTICLE THE PROCTER & GAMBLE COMPANY (US) 2011-05-12 WO disclosed
WO-2007038524-A2 COCRYSTALLIZATION METHODS SSCI, INC. (US) 2007-04-05 WO disclosed
US-6121234-A ORALLY COADMINISTERING TO MAMMAL PHARMACEUTICAL COMPOUND AND ESSENTIAL OIL AVMAX, INC. (US) 2000-09-19 US disclosed
US-5916566-A Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds AVMAX, INC. (US) 1999-06-29 US disclosed
US-5665386-A Use of essential oils to increase bioavailability of oral pharmaceutical compounds AVMAX, INC. (US) 1997-09-09 US disclosed